Figures & data
Table 1. Well-known entities of peripheral neuropathy which are not considered in this review.
Table 2. Studies included in the systematic review.
Ahlawat A, Rana A, Goyal N, et al. Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain. Inflammopharmacology. 2014;22(5):269–278. Alecu I, Tedeschi A, Behler N, et al. Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction. J Lipid Res. 2017;58(1):42–59. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res. 2004;146:477–492. Asahchop EL, Branton WG, Krishnan A, et al. HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction. JCI Insight. 2018;3(23):e122450. Bjornsdottir G, Ivarsdottir EV, Bjarnadottir K, et al. A PRPH splice-donor variant associates with reduced sural nerve amplitude and risk of peripheral neuropathy. Nat Commun. 2019;10(1):1777. Blesneac I, Themistocleous AC, Fratter C, et al. Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy. Pain. 2018;159(3):469–480. Calcutt NA. Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? Pain. 2020;161(Suppl 1):S65–s86. Chandrasekaran K, Anjaneyulu M, Choi J, et al. Role of mitochondria in diabetic peripheral neuropathy: influencing the NAD(+)-dependent SIRT1-PGC-1α-TFAM pathway. Int Rev Neurobiol. 2019;145:177–209. Chen YH, Sasaki Y, DiAntonio A, et al. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration. Exp Neurol. 2021;339:113636. Cheng X, Choi JS, Waxman SG, et al. Mini-review - Sodium channels and beyond in peripheral nerve disease: modulation by cytokines and their effector protein kinases. Neurosci Lett. 2021;741:135446. Cortese A, Lombardi R, Briani C, et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm. 2020;7(1):e639. Elzinga S, Murdock BJ, Guo K, et al. Toll-like receptors and inflammation in metabolic neuropathy; a role in early versus late disease? Exp Neurol. 2019;320:112967. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol. 2012;71(1):26–39. Faivre-Sarrailh C, Devaux JJ. Neuro-glial interactions at the nodes of ranvier: implication in health and diseases. Front Cell Neurosci. 2013;7:196. Fernyhough P, McGavock J. Mechanisms of disease: mitochondrial dysfunction in sensory neuropathy and other complications in diabetes. Handb Clin Neurol. 2014;126:353–377. Fujita Y, Murakami T, Nakamura A. Recent advances in biomarkers and regenerative medicine for diabetic neuropathy. Int J Mol Sci. 2021;22(5):2301. Gonçalves NP, Vaegter CB, Andersen H, et al. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 2017;13(3):135–147. Han C, Huang J, Waxman SG. Sodium channel Nav1.8: emerging links to human disease. Neurology. 2016;86(5):473–483. Harboe M, Aseffa A, Leekassa R. Challenges presented by nerve damage in leprosy. Lepr Rev. 2005;76(1):5–13. Hoeijmakers JG, Merkies IS, Gerrits MM, et al. Genetic aspects of sodium channelopathy in small fiber neuropathy. Clin Genet. 2012;82(4):351–358. Jack M, Wright D. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Transl Res. 2012;159(5):355–365. Kharatmal SB, Singh JN, Sharma SS. Voltage-Gated sodium channels as therapeutic targets for treatment of painful diabetic neuropathy. Mini Rev Med Chem. 2015;15(14):1134–1147. Klatt-Schreiner K, Valek L, Kang JS, et al. High glucosylceramides and low anandamide contribute to sensory loss and pain in parkinson’s disease. Mov Disord. 2020;35(10):1822–1833. Kobayashi M, Zochodne DW. Diabetic neuropathy and the sensory neuron: new aspects of pathogenesis and their treatment implications. J Diabetes Investig. 2018;9(6):1239–1254. Koike H, Katsuno M. Pathophysiology of chronic inflammatory demyelinating polyneuropathy: insights into classification and therapeutic strategy. Neurol Ther. 2020;9(2):213–227. Küçükali CI, Kürtüncü M, Akçay H, et al. Peripheral nerve hyperexcitability syndromes. Rev Neurosci. 2015;26(2):239–251. Kumar V, Sachan T, Natrajan M, et al. High resolution structural changes of schwann cell and endothelial cells in peripheral nerves across leprosy spectrum. Ultrastruct Pathol. 2014;38(2):86–92. Körei AE, Istenes I, Papanas N, et al. Small-Fiber neuropathy: a diabetic microvascular complication of special clinical, diagnostic, and prognostic importance. Angiology. 2016;67(1):49–57. Landerholm ÅH, Hansson PT. Mechanisms of dynamic mechanical allodynia and dysesthesia in patients with peripheral and Central neuropathic pain. Eur J Pain. 2011;15(5):498–503. Landowski LM, Dyck PJ, Engelstad J, et al. Axonopathy in peripheral neuropathies: mechanisms and therapeutic approaches for regeneration. J Chem Neuroanat. 2016;76(Pt A):19–27. Latremoliere A, Costigan M. GCH1, BH4 and pain. Curr Pharm Biotechnol. 2011;12(10):1728–1741. Lehmann HC, Köhne A, Meyer zu Hörste G, et al. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. J Neuropathol Exp Neurol. 2007;66(4):305–312. Martinez AR, Nunes MB, Nucci A, et al. Sensory neuronopathy and autoimmune diseases. Autoimmune Dis. 2012;2012:873587. Meldgaard T, Keller J, Olesen AE, et al. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol. 2019;12:1756284819852047. Moore PM, Cupps TR. Neurological complications of vasculitis. Ann Neurol. 1983;14(2):155–167. Nazıroğlu M, Dikici DM, Dursun S. Role of oxidative stress and Ca2+ signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels. Neurochem Res. 2012;37(10):2065–2075. Perzyńska-Mazan J, Maślińska M, Gasik R. Neurological manifestations of primary sjögren’s syndrome. Reumatologia. 2018;56(2):99–105. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst. 2001;6(1):21–27. Rahman MH, Jha MK, Suk K. Evolving insights into the pathophysiology of diabetic neuropathy: implications of malfunctioning glia and discovery of novel therapeutic targets. Curr Pharm Des. 2016;22(6):738–757. Sántha P, Dobos I, Kis G, et al. Role of gangliosides in peripheral pain mechanisms. Int J Mol Sci. 2020;21(3):1005. Skundric DS, Lisak RP. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res. 2003;4(4):303–312. Sopacua M, Hoeijmakers JGJ, Merkies ISJ, et al. Small-fiber neuropathy: expanding the clinical pain universe. J Peripher Nerv Syst. 2019;24(1):19–33. Teasell RW, Arnold JM. Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheral neuropathic pain and Central pain states following spinal cord injury. Pain Res Manag. 2004;9(2):89–97. Themistocleous AC, Ramirez JD, Serra J, et al. The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol. 2014;14(6):368–379. Tibbs GR, Posson DJ, Goldstein PA. Voltage-Gated ion channels in the PNS: novel therapies for neuropathic pain? Trends Pharmacol Sci. 2016;37(7):522–542. Tomlinson DR, Gardiner NJ. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst. 2008;13(2):112–121. Tsuda M, Koga K, Chen T, et al. Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J Neurochem. 2017;141(4):486–498. Uncini A. A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies. Exp Neurol. 2012;235(2):513–516. Verkhratsky A, Fernyhough P. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium. 2008;44(1):112–122. Vernino S. Autoimmune autonomic disorders. Continuum (Minneap Minn). 2020;26(1):44–57. Ziegler D, Buchholz S, Sohr C, et al. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients. Acta Diabetol. 2015;52(1):65–72.